US 9,868,741 B2Granted

PDE1 inhibitor

AssigneeEli Lilly and Company

InventorCynthia Darshini Jesudason

Life of this patent

Estimating the term…

The present invention provides a compound of Formula I: useful for treating chronic kidney disease and diabetic kidney disease.

Dependent claims

A compound of the formula:

Dependencies are inferred from the claim text.

C07D 487/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/4985
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrazines or piperazines…
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics
A61P 7/12
Drugs for disorders of the blood or the extracellular fluid: antidiuretics, e.g. drugs for diabetes insipidus

From the US filing history. Foreign family members aren’t listed.

Loading patent…